@article {38985,
	title = {Differences in cause and 12-month follow-up outcome of parkinsonian symptoms in depressed older adults treated with antipsychotics: a case series},
	journal = {BMC Psychiatry},
	volume = {21},
	number = {1},
	year = {2021},
	note = {10.1186/s12888-021-03298-9},
	month = {Jun 3},
	pages = {289},
	edition = {20210603},
	abstract = {BACKGROUND: Parkinsonian symptoms are common adverse effects of antipsychotics. Older adults are particularly vulnerable to drug-induced parkinsonism. Nonetheless, parkinsonian symptoms in seniors treated with antipsychotics cannot be straightforwardly attributed to antipsychotic medication. A comprehensive diagnostic workup is necessary in many cases in order to shed light on the cause of such symptoms in this patient population. CASE SERIES: Eight cases of hospitalized depressed older adults with parkinsonian symptoms, who were treated for at least one year with antipsychotics, are reported. Based on neurological consultation, structural brain imaging and Ioflupane (I-123) dopamine transporter (DAT) single photon emission computerized tomography (SPECT), Parkinson{\textquoteright}s disease was diagnosed in one case, idiopathic tremor in another, vascular parkinsonism in another one, while in another individual parkinsonian symptoms persisted at 12-month post-discharge follow-up even though his/her symptoms were classified as drug-induced on discharge. In four patients, parkinsonian symptoms were definitely drug-induced and no movement disturbances were reported at follow-up. CONCLUSIONS: Differences in the cause and outcome of parkinsonian symptoms in seniors treated with antipsychotics merit systematic and in-depth study considering the therapeutic and prognostic implications of an accurate detection of the cause of such symptoms. Familiarizing clinical psychiatrists with these differences could pave the way towards approaching seniors with severe, atypical and/or persistent parkinsonian symptoms in a more individualized diagnostic and therapeutic manner, and towards more cautious prescribing of antipsychotics in this age group.},
	keywords = {*Antipsychotic Agents/adverse effects, *Parkinsonian Disorders/chemically induced/drug therapy, Aftercare, Aged, Case series, Drug induced parkinsonism, Female, Follow-Up Studies, Humans, Idiopathic tremor, Male, Parkinson{\textquoteright}s Disease, Patient Discharge, Tomography, Emission-Computed, Single-Photon, Vascular parkinsonism},
	isbn = {1471-244x},
	author = {Politis, A. and Kokras, N and Souvatzoglou, M. and Siarkos, K. and Toulas, P. and C Potagas and Hatzipanagiotou, T. and Limouris, G. and Alexopoulos, P.}
}
